Travere Therapeutics, Inc. (TVTX)
31.65
-0.18
(-0.57%)
USD |
NASDAQ |
Apr 07, 13:11
Travere Therapeutics SG&A Expense (TTM) : 337.20M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Revolution Medicines, Inc. | 195.04M |
| ICU Medical, Inc. | 625.21M |
| Tandem Diabetes Care, Inc. | 444.99M |
| iRhythm Holdings, Inc. | 492.55M |
| Eli Lilly & Co. | 11.09B |